Unlocking the Value of Combination Therapies
![A gold padlock](https://www.ohe.org/wp-content/uploads/2024/07/unlocking-the-value-of-combination-therapies-scaled.jpeg)
Nadine is an economist by training and is primarily interested in the methodology, processes, and outcomes of health technology assessment. She has experience applying both quantitative and qualitative research methods. Nadine leads the maintenance of OHE’s ‘Medicines Tracker’, a database which records regulatory and HTA (NICE and SMC) information on new medicines.
Her current research interests centre around economic evaluation in health care; she has researched HTA methodological challenges faced by treatments for rare and ultra–rare diseases, histology– independent therapies, and gene therapies. Nadine also has experience conducting research into preference–based measures, including the development of EQ–5D ‘bolt–on’ items and assessing the appropriateness of the EORTC QLU–C10D.
An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!